About YouRad

RadPro is pleased to launch a brand new and innovative radiotherapy forum called “YouRAD Gray matters”.
This is the first UK and International online dedicated radiotherapy opinion poll and survey site. A professional advisory panel has been set up to agree the topics and questions to be asked in each poll. Topics such as “How useful is IMRT” and “Are green issues important in radiotherapy” are two recent suggestions. The setting of poll topics and questions is open to all our readers or NHS trusts, PFI companies, equipment manufacturers, suppliers, recruitment agencies and professional bodies that require feedback on their products and services or have important questions to ask the radiotherapy world. If you have a suggestion please email admin@RadPro.eu.

Each RadPro reader can register themselves as a YouRAD participant and will then be able to have general access to each poll where applicable or may be invited to take part in selected polls. To register you need to leave your email address and answer some simple demographic and professional questions. You will receive one credit for registering, and another for each poll that you partake in. Elekta have sponsored the annual prize draw that will see one lucky participant win a fully paid trip for 2 to ASTRO in the USA. Individual polls may attract individual prizes for participants such as an iPhone or digital camera. The more credits you collect the better the chance of you winning the prize draws! OUR PERSONAL INFORMATION AND ANSWERS TO QUESTIONS WILL NEVER BE PASSED ON TO A THIRD PARTY AND YOU WILL NOT BE CONTACTED FOR MARKETING PURPOSES AS A RESULT OF YOUR PARTICIPATION. YOUR ANSWERS ARE KEPT CONFIDENTIAL AND ARE NEVER PUBLICALLY LINKED TO YOUR PERSONAL INFORMATION. RADPRO WILL ONLY PUBLISH THE RESULTS ON ITS WEBPAGES AND IN A STATISTICAL FORMAT.

Survey 1. How useful is IMRT? Please click on the link below to participate TODAY! There are three branches to this survey, please select the one that applies to you.

Survey 2. The purchase and commissioning of an IGRT system.

Links to the results are at the bottom of this page.

The professional advisory board is as follows.

Dr Ethan Lyn Ethanlyn@mac.com Dr Ethan Lyn is a consultant in clinical oncology at Mount Vernon Hospital. His specialist interests are lung cancer, novel radiotherapy fractionation, implementation of new technology in radiotherapy and quality assurance of clinical trials. He is a member of trial management groups, reviews manuscripts for peer reviewed publications and grant applications and is an advisor to industry.

Dr Ivan Rosenberg ivan.rosenberg@uclh.nhs.uk Dr. Ivan Rosenberg is Consultant Physicist for R&D and former Head of the Radiotherapy Physics Department, UCLH. His career has previously taken him to the Christie Hospital, Royal Marsden Hospital and several institutions in the USA. His specialist interests include the clinical application of new technologies, such as IMRT, IGRT and 4D/Gating, heavy particle therapy, treatment planning systems and radiobiology. He teaches and supervises Medical Physics students at UCL, reviews manuscripts for peer reviewed publications and serves on professional assessments panels for IPEM and HPC.

David Flinton d.m.flinton@city.ac.uk David is a senior lecturer in radiotherapy at City University, London. His main role over the past 4 years has been to ensure the smooth running and continued development of the undergraduate radiotherapy course. He has experience as an external examiner on various radiotherapy programmes within the UK, has also been an external panel member on a number of validations, and was a QAA assessor during the last round of assessments. He is also a category A researcher and regularly reviews manuscripts for peer reviewed publications in his field.

Sarah Hynd DCR (t) Sarah.Hynd@cancerpartnersuk.org Sarah was Head of Radiotherapy Services, at the University College London Hospitals NHS Foundation Trust for 4 years until she joined CancerpartnersUK (CPUK) as Head of Radiotherapy in June 2007. Sarah is a core member of the CPUK management group working alongside Karol Sikora (Medical Director), Rupert Cockroft (CEO) and a recently established clinical team and non- clinical team. CPUK is setting up a unique and new model for radiotherapy and chemotherapy to give access to treatment much nearer to patients’ homes.  CPUK aims to deliver a fresh approach to re-engineering cancer services.

Mark David Shewan markshewan@hotmail.com Mark trained at Newcastle General Hospital - Northern Centre for cancer treatment. He has worked for private hospitals overseas and for several hospitals in England, Scotland and Wales, sharing his knowledge and experience of many different radiotherapy departments. He has many years experience as a specialist therapy radiographer and he is committed to improving treatment delivery, standards of care and student progression.

If you are a reader, Radiotherapy centre, NHS trust, PFI company, equipment manufacturer, supplier, recruitment agency or professional body and you have an important poll topic, please contact admin@RadPro.eu for more information on how to use this new service. The results will be published online at the discretion of the panel or in certain circumstances may remain the property of the body involved.

Proceed to Registration and Surveys

Survey One Results

Survey Two Results